The novel PEGylated interferon-alpha (“Algeron”) plus ribavirin for treatment of chronic hepatitis virus infection: Results from a phase II study
08.08.2017

The novel PEGylated interferon-alpha (“Algeron”) plus ribavirin for treatment of chronic hepatitis virus infection: Results from a phase II study

Chernovskaya T., Ivanov R. , Linkova Yu et al. (2013) “The novel PEGylated interferon-alpha (“Algeron”) plus ribavirin for treatment of chronic hepatitis virus infection: Results from a phase II study”, Cytokine, v. 63,n.3, p. 254.